Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF-Reference-Cited by-同舟云学术

Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF

Published:2015-03-26 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Tinholt Mari,Vollan Hans Kristian Moen,Sahlberg Kristine Kleivi,Jernström Sandra,Kaveh Fatemeh,Lingjærde Ole Christian,Kåresen Rolf,Sauer Torill,Kristensen Vessela,Børresen-Dale Anne-Lise,Sandset Per Morten,Iversen Nina

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0548-5.pdf

Reference50 articles.

1. Falanga A, Russo L, Milesi V. The coagulopathy of cancer. Curr Opin Hematol. 2014;21:423–9.

2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton 3rd LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case–control study. Arch Intern Med. 2000;160:809–15.

3. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293:715–22.

4. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119:648–55.

5. Falanga A, Marchetti M, Vignoli A. Coagulation and cancer: biological and clinical aspects. J Thromb Haemost. 2013;11:223–33.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline polygenic risk scores are associated with immune gene expression signature and immune cell infiltration in breast cancer;The American Journal of Human Genetics;2024-09

2. Cancer progression and tumor hypercoagulability: a platelet perspective;Journal of Thrombosis and Thrombolysis;2024-05-17

3. The breast cancer coagulome in the tumor microenvironment and its role in prognosis and treatment response to chemotherapy;Journal of Thrombosis and Haemostasis;2024-05

4. Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma;Journal of Translational Medicine;2024-04-04

5. The RNA‐binding protein sorbin and SH3 domain‐containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor;Molecular Carcinogenesis;2024-03-19